Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Empty Capsules
Thickeners and Stabilizers
Parenteral
Fillers, Diluents & Binders
Coating Systems & Additives
Co-Processed Excipients
Granulation
Taste Masking
Direct Compression
Controlled & Modified Release
Film Formers & Plasticizers
Topical
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Annual Reports
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Corticotropin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Corticotropin, including repackagers and relabelers. The FDA regulates Corticotropin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Corticotropin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Corticotropin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Corticotropin supplier is an individual or a company that provides Corticotropin active pharmaceutical ingredient (API) or Corticotropin finished formulations upon request. The Corticotropin suppliers may include Corticotropin API manufacturers, exporters, distributors and traders.
click here to find a list of Corticotropin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Corticotropin DMF (Drug Master File) is a document detailing the whole manufacturing process of Corticotropin active pharmaceutical ingredient (API) in detail. Different forms of Corticotropin DMFs exist exist since differing nations have different regulations, such as Corticotropin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Corticotropin DMF submitted to regulatory agencies in the US is known as a USDMF. Corticotropin USDMF includes data on Corticotropin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Corticotropin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Corticotropin suppliers with USDMF on PharmaCompass.
A Corticotropin written confirmation (Corticotropin WC) is an official document issued by a regulatory agency to a Corticotropin manufacturer, verifying that the manufacturing facility of a Corticotropin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Corticotropin APIs or Corticotropin finished pharmaceutical products to another nation, regulatory agencies frequently require a Corticotropin WC (written confirmation) as part of the regulatory process.
click here to find a list of Corticotropin suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Corticotropin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Corticotropin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Corticotropin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Corticotropin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Corticotropin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Corticotropin suppliers with NDC on PharmaCompass.
Corticotropin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Corticotropin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Corticotropin GMP manufacturer or Corticotropin GMP API supplier for your needs.
A Corticotropin CoA (Certificate of Analysis) is a formal document that attests to Corticotropin's compliance with Corticotropin specifications and serves as a tool for batch-level quality control.
Corticotropin CoA mostly includes findings from lab analyses of a specific batch. For each Corticotropin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Corticotropin may be tested according to a variety of international standards, such as European Pharmacopoeia (Corticotropin EP), Corticotropin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Corticotropin USP).
LOOKING FOR A SUPPLIER?
